Form 8-K - Current report:
SEC Accession No. 0001104659-19-069217
Filing Date
2019-12-03
Accepted
2019-12-03 07:50:53
Documents
5
Period of Report
2019-12-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-24358_18k.htm 8-K 27915
2 EX-99.1 a19-24358_1ex99d1.htm EX-99.1 19179
3 GRAPHIC g243581mmi001.jpg GRAPHIC 4051
4 GRAPHIC g243581mmi002.gif GRAPHIC 14335
5 GRAPHIC g243581mmi003.gif GRAPHIC 14085
  Complete submission text file 0001104659-19-069217.txt   93553
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 191264655
SIC: 2834 Pharmaceutical Preparations